These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 20298811)

  • 21. Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy.
    Leung NW; Lai CL; Chang TT; Guan R; Lee CM; Ng KY; Lim SG; Wu PC; Dent JC; Edmundson S; Condreay LD; Chien RN;
    Hepatology; 2001 Jun; 33(6):1527-32. PubMed ID: 11391543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence and determinants of spontaneous seroclearance of hepatitis B e antigen and DNA in patients with chronic hepatitis B.
    Yang HI; Hung HL; Lee MH; Liu J; Jen CL; Su J; Wang LY; Lu SN; You SL; Iloeje UH; Chen CJ;
    Clin Gastroenterol Hepatol; 2012 May; 10(5):527-34.e1-2. PubMed ID: 22178461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection.
    Papatheodoridis GV; Hadziyannis E; Tsochatzis E; Chrysanthos N; Georgiou A; Kafiri G; Manolakopoulos S; Tiniakos DG; Giannousis I; Manesis EK; Archimandritis AJ
    Gut; 2008 Apr; 57(4):500-6. PubMed ID: 18025069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical outcomes of chronic hepatitis B patients with persistently detectable serum hepatitis B virus DNA during lamivudine therapy.
    Kim JH; Yu SK; Seo YS; Yim HJ; Yeon JE; Park JJ; Kim JS; Bak YT; Lee CH; Byun KS
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1220-5. PubMed ID: 17532786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multi-center open study to determine the effect of lamivudine on HBV DNA clearance and to assess the safety of the regimen in patients with chronic hepatitis B infection.
    Mazur W; Król F; Cianciara J; Nazzal K; Gładysz A; Juszczyk J; Bolewska B; Adamek J; Czajka B; Swietek K; Kryczka W; Gonciarz Z
    Med Sci Monit; 2002 Apr; 8(4):CR257-62. PubMed ID: 11951067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Relationship among pathological changes in Liver tissues and level of serum HBV DNA, HBeAg and ALT of 194 patients with chronic hepatitis B].
    Zhao DY; Qin YQ; Tang XM; Liu GZ; Zheng W; Nong HR; Song JJ; Xie QY
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):35-7. PubMed ID: 17429530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamics of hepatitis B e antigen index ratio correlate with treatment response in chronic hepatitis B patients.
    Wang CC; Liu CJ; Lai MY; Kao JH; Chen DS
    Liver Int; 2007 Mar; 27(2):235-9. PubMed ID: 17311619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early mortality in Taiwanese lamivudine-treated patients with chronic hepatitis B-related decompensation: evaluation of the model for end-stage liver disease and index scoring systems as prognostic predictors.
    Dai CY; Chuang WL; Hou NJ; Lee LP; Hsieh MY; Lin ZY; Chen SC; Huang JF; Hsieh MY; Wang LY; Tsai JF; Wen-Yu ; Yu ML
    Clin Ther; 2006 Dec; 28(12):2081-92. PubMed ID: 17296464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
    Sarin SK; Kumar M; Kumar R; Kazim SN; Guptan RC; Sakhuja P; Sharma BC
    Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of baseline viral factors with response to lamivudine therapy in chronic hepatitis B patients with high serum alanine aminotransferase levels.
    Tseng TC; Liu CJ; Wang CC; Chen PJ; Lai MY; Chen DS; Kao JH
    Antivir Ther; 2009; 14(2):203-10. PubMed ID: 19430095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences of YMDD mutational patterns, precore/core promoter mutations, serum HBV DNA levels in lamivudine-resistant hepatitis B genotypes B and C.
    Pan XP; Li LJ; Du WB; Li MW; Cao HC; Sheng JF
    J Viral Hepat; 2007 Nov; 14(11):767-74. PubMed ID: 17927612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serial HBV DNA levels in patients with persistently normal transaminase over 10 years following spontaneous HBeAg seroconversion.
    Chen YC; Huang SF; Chu CM; Liaw YF
    J Viral Hepat; 2012 Feb; 19(2):138-46. PubMed ID: 22239503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine-treated chronic hepatitis B patients.
    Tseng TC; Liu CJ; Wang CC; Chen PJ; Lai MY; Kao JH; Chen DS
    Liver Int; 2008 Aug; 28(7):1034-41. PubMed ID: 18492018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT.
    Kumar M; Sarin SK; Hissar S; Pande C; Sakhuja P; Sharma BC; Chauhan R; Bose S
    Gastroenterology; 2008 May; 134(5):1376-84. PubMed ID: 18471514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significant hepatic histopathology in chronic hepatitis B patients with serum ALT less than twice ULN and high HBV-DNA levels in Indonesia.
    Lesmana CR; Gani RA; Hasan I; Simadibrata M; Sulaiman AS; Pakasi LS; Budihusodo U; Krisnuhoni E; Lesmana LA
    J Dig Dis; 2011 Dec; 12(6):476-80. PubMed ID: 22118698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis E virus as an etiology of acute exacerbation of previously unrecognized asymptomatic patients with hepatitis B virus-related chronic liver disease.
    Kumar M; Sharma BC; Sarin SK
    J Gastroenterol Hepatol; 2008 Jun; 23(6):883-7. PubMed ID: 18070014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Relation of serological markers of hepatitis B virus and alanine transaminase to hepatic tissue pathology in patients with chronic hepatitis B].
    Yang XY; Wen FY; Wu JL; Zhou HJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):892-3. PubMed ID: 16793626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Individualization of interferon therapy using serum hepatitis B virus DNA to reduce viral relapse in patients with chronic hepatitis B: a randomized controlled trial.
    Chung YH; Song BC; Lee GC; Shin JW; Ryu SH; Jung SA; Yoo K; Lee HC; Lee YS; Suh DJ
    Eur J Gastroenterol Hepatol; 2003 May; 15(5):489-93. PubMed ID: 12702905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Viremia profiles in children with chronic hepatitis B virus infection and spontaneous e antigen seroconversion.
    Ni YH; Chang MH; Chen PJ; Tsai KS; Hsu HY; Chen HL; Tsuei DJ; Chen DS
    Gastroenterology; 2007 Jun; 132(7):2340-5. PubMed ID: 17570209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy.
    Liaw YF; Chien RN; Yeh CT; Tsai SL; Chu CM
    Hepatology; 1999 Aug; 30(2):567-72. PubMed ID: 10421670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.